Skip to main content
Terug
Watch Compare

Kezar Life Sciences, Inc.

Datakwaliteit: 100%
KZR
NASDAQ Manufacturing Chemicals
€ 7,39
▼ € 0,04 (-0,54%)
6 months return
—
Momentum
Neutral
ROE
-64,12%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-64,12%
Onder sectorgemiddelde (-54,49%)
ROIC-52,14%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,02
Onder sectorgemiddelde (0,30)
Current Ratio7,06
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-0,97 | -2,76
Boven sectorgemiddelde (-1,50)
P/B Ratio0,65
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -51,79 M

Price History

Financiële Trends

Koersdoel Analisten

2 analisten
Hold
-18.8%
upside to target
Huidig
€ 7,39
Consensus Target
€ 6,00
€ 5,00
Laag
€ 7,00
Hoog
Vooruitzicht
Forward K/W
-2,76
Forward WPA
-€ 2,67
Omzet Sch.
0,0

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 0,98 · Rev Est: 333.330,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 2,00 -€ 1,87 -€ 1,53 -€ 1,05 — —
Estimate -€ 2,65 -€ 2,32 -€ 1,96 -€ 1,31 -€ 0,98 -€ 0,91
Verrassing +24,53% +19,54% +21,81% +19,57% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -64,12% · Net Margin: N/A
Revenue (TTM) 0,0 Net Income (TTM) -56,03 M
ROE -64,12% ROA -54,18%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51,79 M
ROIC -52,14% FCF Growth (3Y) N/A

Safety

D/E: 0,02 · Current: 7,06
Debt / Equity 0,02 Current Ratio 7,06
Interest Coverage N/A Asset Turnover 0,00
Working Capital 81,13 M Tangible Book Value 82,98 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,97 · EV/EBITDA: N/A
P/E Ratio -0,97 Forward P/E -2,76
P/B Ratio 0,65 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -95,71%
Market Cap 54,11 M Enterprise Value 16,55 M

Per Share

EPS: -7,66 · FCF/Share: -7,03
EPS (Diluted TTM) -7,66 Revenue / Share 0,00
FCF / Share -7,03 OCF / Share -7,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 92,42% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 92,42%
SBC-Adj. FCF -62,31 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 7,00 M — —
Net Income -56,03 M -83,74 M -101,87 M -68,24 M -54,63 M
EPS (Diluted) -7,66 -11,49 -1,40 -1,01 —
Gross Profit — — — — —
Operating Income -59,11 M -90,61 M -111,42 M -71,16 M -54,66 M
EBITDA — — — — —
R&D Expenses 33,76 M 65,74 M 85,70 M 51,01 M 38,94 M
SG&A Expenses — — — — —
D&A 897.000,0 1,04 M 1,07 M 1,02 M 1,51 M
Interest Expense — 1,59 M 1,55 M 1,19 M 159.000,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 76,65 M 144,68 M 221,24 M 299,57 M 217,93 M
Total Liabilities 6,57 M 27,77 M 33,67 M 29,70 M 21,06 M
Shareholders' Equity 70,07 M 116,92 M 187,57 M 269,87 M 196,88 M
Total Debt 0,0 5,11 M 10,00 M 10,00 M 10,00 M
Cash & Equivalents 71,88 M 41,75 M 35,49 M 40,46 M 62,88 M
Current Assets 75,73 M 137,49 M 206,95 M 285,72 M 211,65 M
Current Liabilities 6,57 M 20,33 M 17,74 M 11,00 M 8,21 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -1,0 -1,5
P/B 0,7 1,6
ROE % -64,1 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E 0,0 0,3

ETFs Holding This Stock
BRUSX BRUSX
0,36% weight